Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

Eugenia Girda; June Hou; David Nelson; Malcolm Finlayson; Alexandre Buckley de Meritens; Marina Chekmareiva; Aliza Leiser; Mihae Song; Ruth Stephenson; Nancy Chan; Ana I Tergas; Reena Vattakalam; Jason D Wright; Hua Yu; Antons Martincuks; Adrian Kohut; Joycelynne Palmer; Lorna Rodriguez-Rodriguez

doi:10.1136/ijgc-2021-003316

Citation Tools

other Versions

You are currently viewing an earlier version of this article (June 24, 2022).
View the most recent version of this article

PDF

PDF +
Supplementary
Material

Original research

Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Girda E, Hou J, Nelson D, et al

Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

International Journal of Gynecologic Cancer Published Online First: 24 June 2022. doi: 10.1136/ijgc-2021-003316

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password